Viscoelastic and aggregometric point-of-care testing in patients with septic shock - Cross-links between inflammation and haemostasis

Acta Anaesthesiologica Scandinavica

Volumn 56, Issue 10, 2012, Pages 1277-1290

  Brenner, T ^a   Schmidt, K ^a   Delang, M ^a   Mehrabi, A ^a   Bruckner, T ^a   Lichtenstern, C ^b   Martin, E ^a   Weigand, M A ^b   Hofer, S ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ABDOMINAL SURGERY; ADULT; AGED; ARTICLE; ASSAY; AUTOANALYZER; BLOOD IMPEDANCE AGGREGOMETRY; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DISSEMINATED INTRAVASCULAR CLOTTING; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HIGH RISK PATIENT; HUMAN; INFLAMMATION; MALE; POINT OF CARE TESTING; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; SEPSIS; SEPTIC SHOCK; THROMBOCYTE AGGREGATION; THROMBOELASTOMETRY; TIME SERIES ANALYSIS; VISCOELASTICITY;

AGED; APACHE; AREA UNDER CURVE; BLOOD COAGULATION DISORDERS; BLOOD COAGULATION FACTORS; BLOOD VISCOSITY; DISSEMINATED INTRAVASCULAR COAGULATION; FEMALE; HEMOSTASIS; HUMANS; INFLAMMATION; INTERLEUKIN-6; MALE; MIDDLE AGED; PILOT PROJECTS; PLATELET AGGREGATION; POINT-OF-CARE SYSTEMS; POSTOPERATIVE COMPLICATIONS; SHOCK, SEPTIC; SURVIVAL ANALYSIS; THROMBELASTOGRAPHY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84867561914     PISSN: 00015172     EISSN: 13996576     Source Type: Journal    
DOI: 10.1111/j.1399-6576.2012.02750.x     Document Type: Article

References (49)

1. Opal SM, Esmon CT,. Bench-to-bedside review: functional relationships between coagulation and the innate immune response and their respective roles in the pathogenesis of sepsis. Crit Care 2003; 7: 23-38.
2. Levi M, Ten Cate H,. Disseminated intravascular coagulation. N Engl J Med 1999; 341: 586-592.
3. Taylor FB Jr, Toh CH, Hoots WK, Wada H, Levi M,. Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thromb Haemost 2001; 86: 1327-1330.
4. Dempfle CE, Wurst M, Smolinski M, Lorenz S, Osika A, Olenik D, Fiedler F, Borggrefe M,. Use of soluble fibrin antigen instead of -dimer as fibrin-related marker may enhance the prognostic power of the ISTH overt DIC score. Thromb Haemost 2004; 91: 812-818.
5. Gorlinger K, Dirkmann D, Hanke AA, Kamler M, Kottenberg E, Thielmann M, Jakob H, Peters J,. First-line therapy with coagulation factor concentrates combined with point-of-care coagulation testing is associated with decreased allogeneic blood transfusion in cardiovascular surgery: a retrospective, single-center cohort study. Anesthesiology 2011; 115: 1179-1191.
6. Schochl H, Nienaber U, Hofer G, Voelckel W, Jambor C, Scharbert G, Kozek-Langenecker S, Solomon C,. Goal-directed coagulation management of major trauma patients using thromboelastometry (ROTEM)-guided administration of fibrinogen concentrate and prothrombin complex concentrate. Crit Care 2010; 14: R55.
7. Sivula M, Pettila V, Niemi TT, Varpula M, Kuitunen AH,. Thromboelastometry in patients with severe sepsis and disseminated intravascular coagulation. Blood Coagul Fibrinolysis 2009; 20: 419-426.
8. Koch L, Hofer S, Weigand MA, Frommhold D, Poeschl J,. Lipopolysaccharide-induced activation of coagulation in neonatal cord and adult blood monitored by thrombelastography. Thromb Res 2009; 124: 463-467.
9. Adamzik M, Langemeier T, Frey UH, Gorlinger K, Saner F, Eggebrecht H, Peters J, Hartmann M,. Comparison of thrombelastometry with simplified acute physiology score II and sequential organ failure assessment scores for the prediction of 30-day survival: a cohort study. Shock 2011; 35: 339-342.
10. Daudel F, Kessler U, Folly H, Lienert JS, Takala J, Jakob SM,. Thromboelastometry for the assessment of coagulation abnormalities in early and established adult sepsis: a prospective cohort study. Crit Care 2009; 13: R42.
11. Schochl H, Solomon C, Schulz A, Voelckel W, Hanke A, Van Griensven M, Redl H, Bahrami S,. Thromboelastometry (TEM) findings in disseminated intravascular coagulation in a pig model of endotoxinemia. Mol Med 2011; 17: 266-272.
12. Zacharowski K, Sucker C, Zacharowski P, Hartmann M,. Thrombelastography for the monitoring of lipopolysaccharide induced activation of coagulation. Thromb Haemost 2006; 95: 557-561.
13. Adamzik M, Eggmann M, Frey UH, Gorlinger K, Brocker-Preuss M, Marggraf G, Saner F, Eggebrecht H, Peters J, Hartmann M,. Comparison of thromboelastometry with procalcitonin, interleukin 6, and C-reactive protein as diagnostic tests for severe sepsis in critically ill adults. Crit Care 2010; 14: R178.
14. Sibbing D, Braun S, Morath T, Mehilli J, Vogt W, Schomig A, Kastrati A, von, Beckerath N,. Platelet reactivity after clopidogrel treatment assessed with point-of-care analysis and early drug-eluting stent thrombosis. J Am Coll Cardiol 2009; 53: 849-856.
15. Awidi A, Maqablah A, Dweik M, Bsoul N, Abu-Khader A,. Comparison of platelet aggregation using light transmission and multiple electrode aggregometry in Glanzmann thrombasthenia. Platelets 2009; 20: 297-301.
16. Rahe-Meyer N, Winterhalter M, Boden A, Froemke C, Piepenbrock S, Calatzis A, Solomon C,. Platelet concentrates transfusion in cardiac surgery and platelet function assessment by multiple electrode aggregometry. Acta Anaesthesiol Scand 2009; 53: 168-175.
17. DeLong ER, DeLong DM, Clarke-Pearson DL,. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 1988; 44: 837-845.
18. Levi M, Opal SM,. Coagulation abnormalities in critically ill patients. Crit Care 2006; 10: 222.
19. Fourrier F, Chopin C, Goudemand J, Hendrycx S, Caron C, Rime A, Marey A, Lestavel P,. Septic shock, multiple organ failure, and disseminated intravascular coagulation. Compared patterns of antithrombin III, protein C, and protein S deficiencies. Chest 1992; 101: 816-823.
20. Noble S, Pasi J,. Epidemiology and pathophysiology of cancer-associated thrombosis. Br J Cancer 2010; 102 (Suppl. 1): S2-9.
21. Levi M, van der Poll T, ten Cate H, van Deventer SJ,. The cytokine-mediated imbalance between coagulant and anticoagulant mechanisms in sepsis and endotoxaemia. Eur J Clin Invest 1997; 27: 3-9.
22. van der Poll T, Levi M, Hack CE, ten Cate H, van, Deventer SJ, Eerenberg AJ, de, Groot ER, Jansen J, Gallati H, Buller HR., Elimination of interleukin 6 attenuates coagulation activation in experimental endotoxemia in chimpanzees. J Exp Med 1994; 179: 1253-1259.
23. Hack CE, Aarden LA, Thijs LG,. Role of cytokines in sepsis. Adv Immunol 1997; 66: 101-195.
24. Grivennikov SI, Karin M,. Inflammatory cytokines in cancer: tumour necrosis factor and interleukin 6 take the stage. Ann Rheum Dis 2011; 70 (Suppl. 1): i104-108.
25. Collins PW, Macchiavello LI, Lewis SJ, Macartney NJ, Saayman AG, Luddington R, Baglin T, Findlay GP,. Global tests of haemostasis in critically ill patients with severe sepsis syndrome compared to controls. Br J Haematol 2006; 135: 220-227.
26. Haas T, Spielmann N, Mauch J, Madjdpour C, Speer O, Schmugge M, Weiss M,. Comparison of thromboelastometry (ROTEM(R)) with standard plasmatic coagulation testing in paediatric surgery. Br J Anaesth 2012; 108: 36-41.
27. Mahla E, Lang T, Vicenzi MN, Werkgartner G, Maier R, Probst C, Metzler H,. Thromboelastography for monitoring prolonged hypercoagulability after major abdominal surgery. Anesth Analg 2001; 92: 572-577.
28. McCrath DJ, Cerboni E, Frumento RJ, Hirsh AL, Bennett-Guerrero E,. Thromboelastography maximum amplitude predicts postoperative thrombotic complications including myocardial infarction. Anesth Analg 2005; 100: 1576-1583.
29. Nielsen VG, Lyerly RT 3rd, Gurley WQ,. The effect of dilution on plasma coagulation kinetics determined by thrombelastography is dependent on antithrombin activity and mode of activation. Anesth Analg 2004; 99: 1587-1592.
30. Levi M, Lowenberg EC,. Thrombocytopenia in critically ill patients. Semin Thromb Hemost 2008; 34: 417-424.
31. Yaguchi A, Lobo FL, Vincent JL, Pradier O,. Platelet function in sepsis. J Thromb Haemost 2004; 2: 2096-2102.
32. Beijer L, Botting J, Crook P, Oyekan AO, Page CP, Rylander R,. The involvement of platelet activating factor in endotoxin-induced pulmonary platelet recruitment in the guinea-pig. Br J Pharmacol 1987; 92: 803-808.
33. Itoh H, Cicala C, Douglas GJ, Page CP,. Platelet accumulation induced by bacterial endotoxin in rats. Thromb Res 1996; 83: 405-419.
34. Sheu JR, Lee CR, Lin CH, Hsiao G, Ko WC, Chen YC, Yen MH,. Mechanisms involved in the antiplatelet activity of Staphylococcus aureus lipoteichoic acid in human platelets. Thromb Haemost 2000; 83: 777-784.
35. Matera C, Falzarano C, Berrino L, Rossi F,. Effects of tetanus toxin, Salmonella typhimurium porin, and bacterial lipopolysaccharide on platelet aggregation. J Med 1992; 23: 327-338.
36. Cowan DH, Bowman LS, Fratianne RB, Ahmed F,. Platelet aggregation as a sign of septicemia in thermal injury. A prospective study. JAMA 1976; 235: 1230-1234.
37. Gawaz M, Dickfeld T, Bogner C, Fateh-Moghadam S, Neumann FJ,. Platelet function in septic multiple organ dysfunction syndrome. Intensive Care Med 1997; 23: 379-385.
38. Yaguchi A, Pradier O, Lobo F,. Platelet aggregation is impaired at the level of cyclooxygenase and thromboxane synthetase in severe sepsis. Intensive Care Med 2001; 27: S166.
39. Mesters RM, Mannucci PM, Coppola R, Keller T, Ostermann H, Kienast J,. Factor VIIa and antithrombin III activity during severe sepsis and septic shock in neutropenic patients. Blood 1996; 88: 881-886.
40. Niessen RW, Lamping RJ, Jansen PM, Prins MH, Peters M, Taylor FB Jr, de, Vijlder JJ, ten, Cate JW, Hack CE, Sturk A,. Antithrombin acts as a negative acute phase protein as established with studies on HepG2 cells and in baboons. Thromb Haemost 1997; 78: 1088-1092.
41. Moore KL, Andreoli SP, Esmon NL, Esmon CT, Bang NU,. Endotoxin enhances tissue factor and suppresses thrombomodulin expression of human vascular endothelium in vitro. J Clin Invest 1987; 79: 124-130.
42. Moore KL, Esmon CT, Esmon NL,. Tumor necrosis factor leads to the internalization and degradation of thrombomodulin from the surface of bovine aortic endothelial cells in culture. Blood 1989; 73: 159-165.
43. Castellino FJ, Ploplis VA,. The protein C pathway and pathologic processes. J Thromb Haemost 2009; 7 (Suppl. 1): 140-145.
44. Sakata Y, Loskutoff DJ, Gladson CL, Hekman CM, Griffin JH,. Mechanism of protein C-dependent clot lysis: role of plasminogen activator inhibitor. Blood 1986; 68: 1218-1223.
45. Hancock WW, Tsuchida A, Hau H, Thomson NM, Salem HH,. The anticoagulants protein C and protein S display potent antiinflammatory and immunosuppressive effects relevant to transplant biology and therapy. Transplant Proc 1992; 24: 2302-2303.
46. Shorr AF, Bernard GR, Dhainaut JF, Russell JR, Macias WL, Nelson DR, Sundin DP,. Protein C concentrations in severe sepsis: an early directional change in plasma levels predicts outcome. Crit Care 2006; 10: R92.
47. Taylor FB Jr, Chang A, Esmon CT, D'Angelo A, Vigano-D'Angelo S, Blick KE,. Protein C prevents the coagulopathic and lethal effects of Escherichia coli infusion in the baboon. J Clin Invest 1987; 79: 918-925.
48. Levi M, Keller TT, van, Gorp E, ten, Cate H,. Infection and inflammation and the coagulation system. Cardiovasc Res 2003; 60: 26-39.
49. Roeloffzen WW, Kluin-Nelemans HC, Mulder AB, Veeger NJ, Bosman L, de, Wolf JT,. In normal controls, both age and gender affect coagulability as measured by thrombelastography. Anesth Analg 2010; 110: 987-994.